{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T22:34:45Z","timestamp":1792276485579,"version":"4.4.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2021,7,14]],"date-time":"2021-07-14T00:00:00Z","timestamp":1626220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,14]],"date-time":"2021-07-14T00:00:00Z","timestamp":1626220800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000053","name":"U.S. Department of Health & Human Services | NIH | National Eye Institute","doi-asserted-by":"publisher","award":["ZIAEY000490"],"award-info":[{"award-number":["ZIAEY000490"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[2022,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Mutations in the gene for Retinitis Pigmentosa GTPase Regulator (<jats:italic>RPGR<\/jats:italic>) cause the X-linked form of inherited retinal degeneration, and the majority are frameshift mutations in a highly repetitive, purine-rich region of <jats:italic>RPGR<\/jats:italic> known as the OFR15 exon. Truncation of the reading frame in this terminal exon ablates the functionally important C-terminal domain. We hypothesized that targeted excision in ORF15 by CRISPR\/Cas9 and the ensuing repair by non-homologous end joining could restore <jats:italic>RPGR<\/jats:italic> reading frame in a portion of mutant photoreceptors thereby correcting gene function in vivo. We tested this hypothesis in the <jats:italic>rd9<\/jats:italic> mouse, a naturally occurring mutant line that carries a frameshift mutation in <jats:italic>RPGR<\/jats:italic><jats:sup>ORF15<\/jats:sup>, through a combination of germline and somatic gene therapy approaches. In germline gene-edited <jats:italic>rd9<\/jats:italic> mice, probing with RPGR domain-specific antibodies demonstrated expression of full length RPGR<jats:sup>ORF15<\/jats:sup> protein. Hallmark features of RPGR mutation-associated early disease phenotypes, such as mislocalization of cone opsins, were no longer present. Subretinal injections of the same guide RNA (sgRNA) carried in AAV sgRNA and SpCas9 expression vectors restored reading frame of <jats:italic>RPGR<\/jats:italic><jats:sup>ORF15<\/jats:sup> in a subpopulation of cells with broad distribution throughout the retina, confirming successful correction of the mutation. These data suggest that a simplified form of genome editing mediated by CRISPR, as described here, could be further developed to repair <jats:italic>RPGR<\/jats:italic><jats:sup>ORF15<\/jats:sup> mutations in vivo.<\/jats:p>","DOI":"10.1038\/s41434-021-00258-6","type":"journal-article","created":{"date-parts":[[2021,7,14]],"date-time":"2021-07-14T02:03:23Z","timestamp":1626228203000},"page":"81-93","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Restoration of RPGR expression in vivo using CRISPR\/Cas9 gene editing"],"prefix":"10.1038","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4918-6008","authenticated-orcid":false,"given":"Jessica D.","family":"Gumerson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amal","family":"Alsufyani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0125-4358","authenticated-orcid":false,"given":"Wenhan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingqi","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijin","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9537-2573","authenticated-orcid":false,"given":"Tiansen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,14]]},"reference":[{"key":"258_CR1","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1093\/hmg\/5.6.827","volume":"5","author":"R Roepman","year":"1996","unstructured":"Roepman R, Bauer D, Rosenberg T, van Duijnhoven G, van de Vosse E, Platzer M, et al. Identification of a gene disrupted by a microdeletion in a patient with X-linked retinitis pigmentosa (XLRP). Hum Mol Genet. 1996;5:827\u201333.","journal-title":"Hum Mol Genet"},{"key":"258_CR2","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/ng0596-35","volume":"13","author":"A Meindl","year":"1996","unstructured":"Meindl A, Dry K, Herrmann K, Manson F, Ciccodicola A, Edgar A, et al. A gene (RPGR) with homology to the RCC1 guanine nucleotide exchange factor is mutated in X-linked retinitis pigmentosa (RP3). Nat Genet. 1996;13:35\u201342.","journal-title":"Nat Genet"},{"key":"258_CR3","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1086\/379379","volume":"73","author":"D Sharon","year":"2003","unstructured":"Sharon D, Sandberg MA, Rabe VW, Stillberger M, Dryja TP, Berson ELRP2. and RPGR mutations and clinical correlations in patients with X-linked retinitis pigmentosa. Am J Hum Genet. 2003;73:1131\u201346.","journal-title":"Am J Hum Genet"},{"key":"258_CR4","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1038\/78182","volume":"25","author":"R Vervoort","year":"2000","unstructured":"Vervoort R, Lennon A, Bird AC, Tulloch B, Axton R, Miano MG, et al. Mutational hot spot within a new RPGR exon in X-linked retinitis pigmentosa. Nat Genet. 2000;25:462\u20136.","journal-title":"Nat Genet"},{"key":"258_CR5","doi-asserted-by":"publisher","first-page":"3649","DOI":"10.1073\/pnas.97.7.3649","volume":"97","author":"DH Hong","year":"2000","unstructured":"Hong DH, Pawlyk BS, Shang J, Sandberg MA, Berson EL, Li T. A retinitis pigmentosa GTPase regulator (RPGR)-deficient mouse model for X-linked retinitis pigmentosa (RP3). Proc Natl Acad Sci USA. 2000;97:3649\u201354.","journal-title":"Proc Natl Acad Sci USA"},{"key":"258_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/13816810.2010.535889","volume":"32","author":"J Hosch","year":"2011","unstructured":"Hosch J, Lorenz B, Stieger K. RPGR: role in the photoreceptor cilium, human retinal disease, and gene therapy. Ophthalmic Genet. 2011;32:1\u201311.","journal-title":"Ophthalmic Genet"},{"key":"258_CR7","doi-asserted-by":"publisher","first-page":"e35865","DOI":"10.1371\/journal.pone.0035865","volume":"7","author":"DA Thompson","year":"2012","unstructured":"Thompson DA, Khan NW, Othman MI, Chang B, Jia L, Grahek G, et al. Rd9 is a naturally occurring mouse model of a common form of retinitis pigmentosa caused by mutations in RPGR-ORF15. PLoS One. 2012;7:e35865.","journal-title":"PLoS One"},{"key":"258_CR8","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/978-3-319-75402-4_64","volume":"1074","author":"H Khanna","year":"2018","unstructured":"Khanna H. More than meets the eye: current understanding of RPGR function. Adv Exp Med Biol. 2018;1074:521\u201338.","journal-title":"Adv Exp Med Biol"},{"key":"258_CR9","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S0092-8674(00)00023-4","volume":"102","author":"JR Marszalek","year":"2000","unstructured":"Marszalek JR, Liu X, Roberts EA, Chui D, Marth JD, Williams DS, et al. Genetic evidence for selective transport of opsin and arrestin by kinesin-II in mammalian photoreceptors. Cell. 2000;102:175\u201387.","journal-title":"Cell"},{"key":"258_CR10","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.exer.2005.10.026","volume":"82","author":"D Jimeno","year":"2006","unstructured":"Jimeno D, Lillo C, Roberts EA, Goldstein LS, Williams DS. Kinesin-2 and photoreceptor cell death: requirement of motor subunits. Exp Eye Res. 2006;82:351\u20133.","journal-title":"Exp Eye Res"},{"key":"258_CR11","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1083\/jcb.200107108","volume":"157","author":"GJ Pazour","year":"2002","unstructured":"Pazour GJ, Baker SA, Deane JA, Cole DG, Dickert BL, Rosenbaum JL, et al. The intraflagellar transport protein, IFT88, is essential for vertebrate photoreceptor assembly and maintenance. J Cell Biol. 2002;157:103\u201313.","journal-title":"J Cell Biol"},{"key":"258_CR12","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1093\/hmg\/8.8.1571","volume":"8","author":"R Kirschner","year":"1999","unstructured":"Kirschner R, Rosenberg T, Schultz-Heienbrok R, Lenzner S, Feil S, Roepman R, et al. RPGR transcription studies in mouse and human tissues reveal a retina-specific isoform that is disrupted in a patient with X-linked retinitis pigmentosa. Hum Mol Genet. 1999;8:1571\u20138.","journal-title":"Hum Mol Genet"},{"key":"258_CR13","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1038\/gt.2015.93","volume":"23","author":"BS Pawlyk","year":"2016","unstructured":"Pawlyk BS, Bulgakov OV, Sun X, Adamian M, Shu X, Smith AJ, et al. Photoreceptor rescue by an abbreviated human RPGR gene in a murine model of X-linked retinitis pigmentosa. Gene Ther. 2016;23:196\u2013204.","journal-title":"Gene Ther"},{"key":"258_CR14","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1167\/iovs.04-1065","volume":"46","author":"DH Hong","year":"2005","unstructured":"Hong DH, Pawlyk BS, Adamian M, Sandberg MA, Li T. A single, abbreviated RPGR-ORF15 variant reconstitutes RPGR function in vivo. Invest Ophthalmol Vis Sci. 2005;46:435\u201341.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"258_CR15","doi-asserted-by":"publisher","first-page":"E2925","DOI":"10.1073\/pnas.1523201113","volume":"113","author":"X Sun","year":"2016","unstructured":"Sun X, Park JH, Gumerson J, Wu Z, Swaroop A, Qian H, et al. Loss of RPGR glutamylation underlies the pathogenic mechanism of retinal dystrophy caused by TTLL5 mutations. Proc Natl Acad Sci USA. 2016;113:E2925\u201334.","journal-title":"Proc Natl Acad Sci USA"},{"key":"258_CR16","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1086\/340848","volume":"70","author":"DK Breuer","year":"2002","unstructured":"Breuer DK, Yashar BM, Filippova E, Hiriyanna S, Lyons RH, Mears AJ, et al. A comprehensive mutation analysis of RP2 and RPGR in a North American cohort of families with X-linked retinitis pigmentosa. Am J Hum Genet. 2002;70:1545\u201354.","journal-title":"Am J Hum Genet"},{"key":"258_CR17","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1016\/j.ymthe.2017.05.004","volume":"25","author":"WA Beltran","year":"2017","unstructured":"Beltran WA, Cideciyan AV, Boye SE, Ye GJ, Iwabe S, Dufour VL, et al. Optimization of retinal gene therapy for X-linked retinitis pigmentosa due to RPGR mutations. Mol Ther. 2017;25:1866\u201380.","journal-title":"Mol Ther"},{"key":"258_CR18","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1016\/j.ymthe.2017.05.005","volume":"25","author":"MD Fischer","year":"2017","unstructured":"Fischer MD, McClements ME, Martinez-Fernandez de la Camara C, Bellingrath JS, Dauletbekov D, Ramsden SC, et al. Codon-optimized RPGR improves stability and efficacy of AAV8 gene therapy in two mouse models of X-linked retinitis pigmentosa. Mol Ther. 2017;25:1854\u201365.","journal-title":"Mol Ther"},{"key":"258_CR19","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1038\/s41591-020-0763-1","volume":"26","author":"J Cehajic-Kapetanovic","year":"2020","unstructured":"Cehajic-Kapetanovic J, Xue K, Martinez-Fernandez de la Camara C, Nanda A, Davies A, Wood LJ, et al. Initial results from a first-in-human gene therapy trial on X-linked retinitis pigmentosa caused by mutations in RPGR. Nat Med. 2020;26:354\u20139.","journal-title":"Nat Med"},{"key":"258_CR20","doi-asserted-by":"publisher","first-page":"3956","DOI":"10.1093\/hmg\/ddv134","volume":"24","author":"Z Wu","year":"2015","unstructured":"Wu Z, Hiriyanna S, Qian H, Mookherjee S, Campos MM, Gao C, et al. A long-term efficacy study of gene replacement therapy for RPGR-associated retinal degeneration. Hum Mol Genet. 2015;24:3956\u201370.","journal-title":"Hum Mol Genet"},{"key":"258_CR21","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1089\/hum.2015.035","volume":"26","author":"WT Deng","year":"2015","unstructured":"Deng WT, Dyka FM, Dinculescu A, Li J, Zhu P, Chiodo VA, et al. Stability and safety of an AAV vector for treating RPGR-ORF15 X-linked retinitis pigmentosa. Hum Gene Ther. 2015;26:593\u2013602.","journal-title":"Hum Gene Ther"},{"key":"258_CR22","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1089\/hum.2018.193","volume":"30","author":"KT McCullough","year":"2019","unstructured":"McCullough KT, Boye SL, Fajardo D, Calabro K, Peterson JJ, Strang CE, et al. Somatic gene editing of GUCY2D by AAV-CRISPR\/Cas9 alters retinal structure and function in mouse and macaque. Hum Gene Ther. 2019;30:571\u201389.","journal-title":"Hum Gene Ther"},{"key":"258_CR23","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1146\/annurev-biochem-060815-014607","volume":"85","author":"H Wang","year":"2016","unstructured":"Wang H, La Russa M, Qi LS. CRISPR\/Cas9 in genome editing and beyond. Annu Rev Biochem. 2016;85:227\u201364.","journal-title":"Annu Rev Biochem"},{"key":"258_CR24","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.preteyeres.2018.03.003","volume":"65","author":"ER Burnight","year":"2018","unstructured":"Burnight ER, Giacalone JC, Cooke JA, Thompson JR, Bohrer LR, Chirco KR, et al. CRISPR-Cas9 genome engineering: treating inherited retinal degeneration. Prog Retin Eye Res. 2018;65:28\u201349.","journal-title":"Prog Retin Eye Res"},{"key":"258_CR25","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/mt.2015.220","volume":"24","author":"B Bakondi","year":"2016","unstructured":"Bakondi B, Lv W, Lu B, Jones MK, Tsai Y, Kim KJ, et al. In vivo CRISPR\/Cas9 gene editing corrects retinal dystrophy in the S334ter-3 rat model of autosomal dominant retinitis pigmentosa. Mol Ther. 2016;24:556\u201363.","journal-title":"Mol Ther"},{"key":"258_CR26","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1093\/hmg\/ddx438","volume":"27","author":"SG Giannelli","year":"2018","unstructured":"Giannelli SG, Luoni M, Castoldi V, Massimino L, Cabassi T, Angeloni D, et al. Cas9\/sgRNA selective targeting of the P23H Rhodopsin mutant allele for treating retinitis pigmentosa by intravitreal AAV9.PHP.B-based delivery. Hum Mol Genet. 2018;27:761\u201379.","journal-title":"Hum Mol Genet"},{"key":"258_CR27","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1016\/j.ophtha.2018.04.001","volume":"125","author":"YT Tsai","year":"2018","unstructured":"Tsai YT, Wu WH, Lee TT, Wu WP, Xu CL, Park KS, et al. Clustered regularly interspaced short palindromic repeats-based genome surgery for the treatment of autosomal dominant retinitis pigmentosa. Ophthalmology. 2018;125:1421\u201330.","journal-title":"Ophthalmology"},{"key":"258_CR28","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1016\/j.stemcr.2018.05.012","volume":"10","author":"WL Deng","year":"2018","unstructured":"Deng WL, Gao ML, Lei XL, Lv JN, Zhao H, He KW, et al. Gene correction reverses ciliopathy and photoreceptor loss in iPSC-derived retinal organoids from retinitis pigmentosa patients. Stem Cell Reports. 2018;10:2005.","journal-title":"Stem Cell Reports"},{"key":"258_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/srep19969","volume":"6","author":"AG Bassuk","year":"2016","unstructured":"Bassuk AG, Zheng A, Li Y, Tsang SH, Mahajan VB. Precision medicine: genetic repair of retinitis pigmentosa in patient-derived stem cells. Sci Rep. 2016;6:19969.","journal-title":"Sci Rep"},{"key":"258_CR30","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/S0042-6989(01)00146-8","volume":"42","author":"B Chang","year":"2002","unstructured":"Chang B, Hawes NL, Hurd RE, Davisson MT, Nusinowitz S, Heckenlively JR. Retinal degeneration mutants in the mouse. Vision Res. 2002;42:517\u201325.","journal-title":"Vision Res"},{"key":"258_CR31","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1101\/gr.186379.114","volume":"25","author":"GK Varshney","year":"2015","unstructured":"Varshney GK, Pei W, LaFave MC, Idol J, Xu L, Gallardo V, et al. High-throughput gene targeting and phenotyping in zebrafish using CRISPR\/Cas9. Genome Res. 2015;25:1030\u201342.","journal-title":"Genome Res"},{"key":"258_CR32","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/bs.pmbts.2018.05.001","volume":"159","author":"AP Chandrasekaran","year":"2018","unstructured":"Chandrasekaran AP, Song M, Kim KS, Ramakrishna S. Different methods of delivering CRISPR\/Cas9 into cells. Prog Mol Biol Transl Sci. 2018;159:157\u201376.","journal-title":"Prog Mol Biol Transl Sci"},{"key":"258_CR33","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.cell.2013.04.025","volume":"153","author":"H Wang","year":"2013","unstructured":"Wang H, Yang H, Shivalila CS, Dawlaty MM, Cheng AW, Zhang F, et al. One-step generation of mice carrying mutations in multiple genes by CRISPR\/Cas-mediated genome engineering. Cell. 2013;153:910\u20138.","journal-title":"Cell"},{"key":"258_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14716","volume":"8","author":"W Yu","year":"2017","unstructured":"Yu W, Mookherjee S, Chaitankar V, Hiriyanna S, Kim JW, Brooks M, et al. Nrl knockdown by AAV-delivered CRISPR\/Cas9 prevents retinal degeneration in mice. Nat Commun. 2017;8:14716.","journal-title":"Nat Commun"},{"key":"258_CR35","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/978-1-4939-9139-6_7","volume":"1950","author":"W Yu","year":"2019","unstructured":"Yu W, Wu Z. Use of AAV vectors for CRISPR-mediated in vivo genome editing in the retina. Methods Mol Biol. 2019;1950:123\u201339.","journal-title":"Methods Mol Biol"},{"key":"258_CR36","doi-asserted-by":"publisher","first-page":"3954","DOI":"10.1167\/iovs.07-0257","volume":"48","author":"SC Khani","year":"2007","unstructured":"Khani SC, Pawlyk BS, Bulgakov OV, Kasperek E, Young JE, Adamian M, et al. AAV-mediated expression targeting of rod and cone photoreceptors with a human rhodopsin kinase promoter. Invest Ophthalmol Vis Sci. 2007;48:3954\u201361.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"258_CR37","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1080\/14712598.2020.1680635","volume":"20","author":"C Martinez-Fernandez De La Camara","year":"2020","unstructured":"Martinez-Fernandez De La Camara C, Cehajic-Kapetanovic J, MacLaren RE. RPGR gene therapy presents challenges in cloning the coding sequence. Expert Opin Biol Ther. 2020;20:63\u201371.","journal-title":"Expert Opin Biol Ther"},{"key":"258_CR38","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.molcel.2018.11.031","volume":"73","author":"AM Chakrabarti","year":"2019","unstructured":"Chakrabarti AM, Henser-Brownhill T, Monserrat J, Poetsch AR, Luscombe NM, Scaffidi P. Target-specific precision of CRISPR-mediated genome editing. Mol Cell. 2019;73:699\u2013713 e6.","journal-title":"Mol Cell"},{"key":"258_CR39","doi-asserted-by":"publisher","first-page":"7720","DOI":"10.1073\/pnas.1213431110","volume":"110","author":"LN Truong","year":"2013","unstructured":"Truong LN, Li Y, Shi LZ, Hwang PY, He J, Wang H, et al. Microhomology-mediated end joining and homologous recombination share the initial end resection step to repair DNA double-strand breaks in mammalian cells. Proc Natl Acad Sci USA. 2013;110:7720\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"258_CR40","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/s42003-019-0705-y","volume":"2","author":"BM Sansbury","year":"2019","unstructured":"Sansbury BM, Hewes AM, Kmiec EB. Understanding the diversity of genetic outcomes from CRISPR-Cas generated homology-directed repair. Commun Biol. 2019;2:458.","journal-title":"Commun Biol"},{"key":"258_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-018-4758-y","volume":"19","author":"J Zheng","year":"2018","unstructured":"Zheng J, Li H, Zhang Q, Sun L, Liu X, Luo C. Homologous recombination occurs frequently at innate GT microsatellites in normal somatic and germ cells in vivo. BMC Genomics. 2018;19:359.","journal-title":"BMC Genomics"}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41434-021-00258-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41434-021-00258-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41434-021-00258-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,29]],"date-time":"2022-10-29T08:05:37Z","timestamp":1667030737000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41434-021-00258-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,14]]},"references-count":41,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["258"],"URL":"https:\/\/doi.org\/10.1038\/s41434-021-00258-6","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,14]]},"assertion":[{"value":"13 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}